Russia’s antitrust regulator, the Federal Antimonopoly service (FAS), opened an investigation into possible cartel behavior from 5 companies offering medical supplies and equipment through public sector auctions across the Russian Federation.
The companies being investigated include Metrolife, Promezhutki, Medtorg, Infamed and Micromed. The companies are suspected of maintaining prices at auctions of cardiology products. According to the FAS, the companies colluded on at least 357 auctions from 2015 to 2017.
The FAS stated that the “potential cartel is one of the largest scale. The amount of initial maximum prices of contracts amounted to more than 2.5 billion rubles (US$42.1 million).”
Full Content: FreeNews English
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI